IngredientsAmylopectin is a water-insoluble polysaccharide and highly branched polymer of α-glucose units found in plants. It is one of the two components of starch, the other being amylose, and plants store starch within specialized organelles called amyloplasts.
Amylopectin is a branched-chain polysaccharide composed of glucose units linked primarily by α-1,4-glycosidic bonds but with occasional α-1,6-glycosidic bonds, which are responsible for the branching. A molecule of amylopectin may contain many thousands of glucose units with branch points occurring about every 25–30 units. Methylation and periodate oxidation studies established that the α-D-glucopyranose residues are joined mainly by (1→4) bonds with 4–5% joined by (1→6) bonds.
For amylopectin, the major, well-organized, branched part of starch, two main molecular representations describe its structure: the classical cluster model and the more recent backbone model. The accumulated molecular and functional data support the backbone model, and it well accommodates current knowledge related to the biosynthesis of starch.
Both amylopectin and glycogen contain branch points that are linked through α-1,6-linkages, though these branch points occur more often in glycogen. This structural similarity to glycogen — the human body's own carbohydrate-storage polymer — is the foundation for amylopectin's use as a sports nutrition ingredient.
Starch is made of about 70–80% amylopectin by weight, though it varies depending on the source — ranging from lower percent content in long-grain rice, amylomaize, and russet potatoes to 100% in glutinous rice, waxy potato starch, and waxy corn.
Waxy starches from varietals of potatoes, corn (maize), and barley are high in amylopectin and low in amylose; amylopectin is less resistant to digestion because its glucose chains are more highly branched compared with amylose.
Typical non-waxy starches have amounts of amylopectin in the range of 70–85%, whereas inhibited waxy starches based on maize, wheat, or tapioca have an amylopectin content in the range of 95–100%. The high degree of amylopectin provides waxy starches with different properties than non-waxy starches, including higher viscosity, formation of longer and more cohesive pastes, and higher resistance to retrogradation.
As a dietary supplement, amylopectin is most commonly derived from waxy maize (waxy corn starch), a variety of Zea mays with a starch content of nearly 100% amylopectin. It is commercially available as:
While amylopectin as an isolated substance is a modern construct, its primary food vehicle — high-amylopectin "waxy" or "glutinous" cereals — has an extraordinarily deep history in Asian cultures.
Archaeobotany, culture, history, and ethnobotany trace the history of the development of sticky (or glutinous) cereal forms. True sticky rice is the result of a genetic mutation that causes a loss of amylose starch but higher amylopectin content, and these mutations are unknown in wild populations but have become important amongst cultivars in East and Southeast Asia.
This points to a strong role for cultural history and food preparation traditions in the genetic selection and breeding of Asian cereal varieties. The importance of sticky rice in ritual foods and alcoholic beverages in East and Southeast Asia also suggests the entanglement of crop varieties and culturally inherited food traditions and ritual symbolism.
Cultural preference for waxy starch acted as a strong selective force on the genetics of crops, because waxy forms that are unknown in the wild can be found in East Asia today in some landraces of most cereals, including rice, millets (Panicum miliaceum, Setaria italica), sorghum, barley, Job's tears (Coix lachryma-jobi) and even maize.
Made from sticky rice, ancient Chinese li (a fermented beverage) has been used since at least the Eastern Zhou period (770–220 BC), as noted in the Old Chinese Book of Odes. In many cases, glutinous rice has been grown exclusively to make rice wine, and such wines feature widely in Asian festivals and spiritual offerings. Rice wines are widespread across the region — as chouju or huang jiu in China, doburoku or sake in Japan, gamju in Korea, ruou in Vietnam, or Thai sato.
Glutinous rice has been cultivated and savoured across Asia for millennia. The natural stickiness and sweetish flavour make it a versatile dessert and pastry ingredient in various cultures. Famed dishes include Chinese zongzi rice dumplings, sweet tang yuan dessert soup, Malaysian lemang bamboo rice, Thai mango sticky rice, and the rice-flour base for Japanese daifuku and mochi.
Due to the sweeter nature of amylopectins, waxy cereals are often preferred in traditional food preparations. In Laos, glutinous rice occupies a particularly central role: about 85% of all the rice grown in Laos is glutinous rice, and it has been part of their culture for at least 1,100 years.
High-amylopectin grains were traditionally selected, cultivated, and prepared in culturally specific ways — primarily steaming rather than boiling. When steamed, the amylopectin molecules are released, giving the rice its tender stickiness; unlike regular white rice, which is cooked by boiling in water, glutinous rice is traditionally steamed. These foods served multiple roles: as everyday staple foods in some communities (particularly Laos), as fermentation substrates for alcohol production, and as ceremonial or ritual foods at festivals, weddings, and spiritual events throughout East and Southeast Asia.
The use of amylopectin as an isolated supplement ingredient is an entirely modern development, emerging in the sports nutrition industry in the late 1990s and early 2000s, building on food science and exercise physiology research.
As a pure polysaccharide, amylopectin does not contain secondary phytochemical "active compounds" in the botanical supplement sense. Its activity derives entirely from its molecular structure and consequent digestive behavior.
Starch contains two polymers composed of glucose units: amylose (linear) and amylopectin (branched). Glycogen is a storage form of energy in animals and is also a branched polymer composed of glucose units, but is more highly branched than amylopectin. Because amylopectin and glycogen share this branched α-glucan architecture, amylopectin-rich starch is digested by the same amylase enzymes the body uses to access its own glycogen stores.
To generate energy, the plant hydrolyzes starch, releasing glucose subunits. Humans and other animals that eat plant foods also use amylase, an enzyme that assists in breaking down amylopectin, to initiate the hydrolysis of starch. The extensively branched structure of amylopectin presents many more enzyme-accessible chain ends simultaneously compared with the linear amylose chain, which is proposed to account for its characteristically rapid enzymatic digestion.
The botanical origin of starch determines the amylose/amylopectin ratio, and the ratio between these two molecules impacts the rate and extent of starch digestibility, with amylose being digested more slowly than amylopectin.
The primary proposed mechanism for amylopectin's sports nutrition applications is accelerated delivery of glucose to the bloodstream and muscles via rapid enzymatic digestion. Because amylopectin may lead to a rapid increase in blood glucose and insulin concentrations, an amylopectin/chromium complex has been studied for its ability to augment exercise-induced muscle protein synthesis.
The glycemic effect of foods depends on various factors, including the type of starch (amylose versus amylopectin), physical entrapment of starch molecules within the food, and fat and protein content of the food.
Amylopectin is a starch found in plants, while chromium is an essential trace element that supports glucose metabolism. The combination of chromium and amylopectin may increase insulin's ability to carry amino acids to muscle cells, which may help to increase strength and power by accelerating and boosting muscle protein synthesis (MPS).
Chromium has an important effect on improving insulin action and increasing the metabolism of nutrients including carbohydrates, lipids, proteins, and nucleic acids by activation of enzymes involved in linked pathways including glucose transporters (GLUTs), insulin receptor substrate-1 (IRS-1), and fatty acid synthase (FAS).
Several studies have shown that the combination of carbohydrates and protein after exercise replenishes muscle glycogen more efficiently than consumption of carbohydrates alone. In the context of amylopectin/chromium research, investigators have hypothesized that insulin stimulated by this combination activates the mammalian target of rapamycin (mTOR) signaling pathway, which regulates muscle protein synthesis. However, to date, no studies have reported on the detailed mechanisms of action (e.g., mTOR pathway) of BCAAs combined with an amylopectin/chromium complex in humans.
One mechanism proposed to distinguish waxy maize amylopectin from lower-molecular-weight carbohydrate sources such as dextrose or maltodextrin is its lower osmolality in solution. High osmolality in the stomach can delay gastric emptying and cause gastrointestinal discomfort; a solution of the very large amylopectin molecules at the same gram-per-gram carbohydrate dose produces far fewer particles per unit volume and therefore much lower osmolality, theoretically supporting more rapid gastric transit during exercise.
Evidence summary: Moderate — multiple human RCTs, consistent direction, some conflicting results for exercise contexts.
A body of human clinical research has directly compared the postprandial metabolic effects of high-amylopectin versus high-amylose starches.
In a study of twelve women and thirteen men given meals containing cornstarch with 70% of the starch in the form of amylopectin or amylose at a dose of 1 g carbohydrate per kilogram body weight, the amylose meal resulted in a significantly lower glucose peak at 30 minutes than did the amylopectin meal. Plasma insulin response was significantly lower 30 and 60 minutes after amylose than after the amylopectin meal, and summed insulin above fasting was significantly lower after amylose.
In a crossover study where twelve men consumed a diet containing 34% of calories as 70% amylose or amylopectin starch for 5 weeks each, no significant differences were observed in glucose or insulin levels after 4 weeks on each starch; however, after 5 weeks, glucose and insulin responses were significantly lower when a meal containing amylose compared with amylopectin was consumed. Summed insulin over 0.5 through 2 hours was significantly lower after amylose compared with amylopectin. Mean fasting triglyceride and cholesterol levels were also significantly lower during the period when amylose was consumed, and the authors concluded that long-term intake of dietary amylose may be valuable in decreasing insulin response while maintaining proper control of glucose tolerance and low levels of blood lipids.
A 2009 study (Sands et al., Nutrition Research) directly examined waxy maize starch in humans: examining the postprandial metabolic and appetitive responses of waxy maize starch (WM), a slow-digestible starch, twelve subjects (6 men and 6 women, age 23 ± 1 years, BMI 22.2 ± 0.7 kg/m²) consumed, on separate days, 50 g of available carbohydrate as WM, a maltodextrin-sucrose mixture, or white bread. Results established in humans that consumption of WM leads to blunted postprandial glucose and insulin responses, potentially leading to a more steady supply and release of energy over a period, compared to the rapidly digesting starch maltodextrin. Although these results are consistent with previous research in other types of slow-digestible starches, the authors noted they should be viewed as preliminary, and the precision and accuracy of the glycemic and insulinemic responses of waxy maize confirmed with other research.
A systematic review and meta-analysis of 25 randomized crossover trials (n=369 participants) published in the American Journal of Clinical Nutrition assessed the impact of starchy food structure on postprandial response. The review identified that 6 trials evaluated the amylose-to-amylopectin ratio, and meta-analyses showed that significant reductions in postprandial glucose and insulin levels were caused by starch with a high amylose content [standardized mean difference = −0.64 mmol/L·min (95% CI: −0.83 to −0.46) for glucose and SMD = −0.81 pmol/L·min (95% CI: −1.07 to −0.55) for insulin]. This finding — that more amylose (and therefore less amylopectin) produces lower glycemic responses — underscores the fundamentally high glycemic character of amylopectin-dominant starches.
Limitation: Results for waxy maize starch specifically are sometimes paradoxical. Different processing methods (raw, hydrothermally treated, heat-modified) substantially alter digestion rate, making it difficult to generalize findings across commercial products with the same "amylopectin" label.
Evidence summary: Preliminary to moderate — small human studies; results are mixed, with some advantage seen over glucose in specific contexts but not others.
The landmark study most cited in this area was published in the International Journal of Sports Medicine (Jozsi et al., 1996). The study was designed to evaluate the influence of starch structure on muscle glycogen resynthesis and cycling performance. Eight male cyclists (22 ± 1 years) completed an exercise protocol to decrease vastus lateralis glycogen concentration, consisting of 60 minutes of cycling at 75% VO2max followed by six 1-minute sprints at approximately 125% VO2max. In the 12 hours after exercise, each subject consumed approximately 3,000 kcal (65:20:15% carbohydrate, fat, and protein), with all carbohydrate derived from one of four solutions: 1) glucose, 2) maltodextrin, 3) waxy starch (100% amylopectin), or 4) resistant starch (100% amylose).
Research by Piehl Aulin, Soderlund, and Hultman (2000, European Journal of Applied Physiology) examined muscle glycogen resynthesis rates and found that mean glycogen synthesis rate was significantly higher during the initial 2 hours for a high-molecular-weight carbohydrate drink (C group) compared to a glucose drink (G group): 50.2 (SD 13.7) mmol/kg dry mass/h in the C group versus 29.9 (SD 12.5) mmol/kg dry mass/h in the G group. Mean blood glucose and insulin concentrations did not differ between the two drinks, suggesting that the osmolality of the carbohydrate drink may influence the rate of resynthesis of glycogen in muscle after its depletion by exercise.
Earlier investigations using prolonged endurance exercise protocols and post-exercise 100% or 78% amylopectin supplementation had reported significantly greater resynthesis of lost muscle glycogen, providing context for the hypothesis that amylopectin may support superior glycogen recovery compared to other carbohydrates. However, these results have not been consistently replicated under all conditions.
Evidence summary: Preliminary — small human studies; attenuated glycemic/insulinemic response confirmed, direct performance benefit not established.
Roberts et al. (2011, Nutrition) conducted a human crossover trial examining a hydrothermally modified high-molecular-weight waxy maize starch. Nine male cyclists (30 ± 2 years, 79.2 ± 2.1 kg) fasted 10 hours before cycling for 150 minutes at 70% peak oxygen consumption and then completing a cycling-to-exhaustion trial at 100% peak oxygen consumption. Participants ingested 1 g/kg of HMS or maltodextrin 30 minutes before and within 10 minutes of completing the bout. Blood samples were provided every 15 minutes before, during, and 90 minutes after exercise. Testing was completed in a crossover, randomized, and double-blind fashion. Primary findings included that increases in serum glucose were greater during maltodextrin (peak 9.5 mM) versus HMS (peak 7.4 mM, P ≤ 0.01), and insulin levels were significantly lower during HMS (peak 2.5 μIU/mL) versus maltodextrin (peak 20.3 μIU/mL). A hydrothermally processed maize starch has been shown to blunt the initial blood glucose and insulin response during endurance activity at 70% maximal oxygen uptake (VO2max). However, this study did not demonstrate a performance advantage in a high-intensity time-to-exhaustion test.
Evidence summary: Preliminary — one small human RCT (industry-funded), one preclinical (rat) study; results are promising but evidence base is narrow.
The most clinically studied application of isolated amylopectin in recent years involves its combination with chromium as the patented ingredient Velositol®.
A study published in the Journal of the International Society of Sports Nutrition showed the combination of amylopectin and chromium in Nutrition 21's patented ingredient Velositol doubled the muscle protein synthesis (MPS) rate compared to what was seen when using whey protein alone. The randomized, double-blind, single-dose, active-controlled crossover study was conducted at The Center for Applied Health Sciences in Stow, Ohio, on 10 healthy men and women ages 22–34, who on two different occasions were given a single dose of Velositol with 6 grams of whey protein or 6 grams of whey protein alone, and completed eight sets of bilateral leg press exercise.
Prior clinical research showed that adding a patented complex of chromium picolinate, chromium histidinate and amylopectin (Velositol) to a single 6-gram dose of whey protein increased baseline exercise-induced muscle protein synthesis by 48% vs. a 24% increase from the same dose of protein alone. The goal of a subsequent clinical study was to extend these findings by examining chronic changes in muscle strength, fat-free mass, whole-body protein balance, and exercise performance during 8 weeks of resistance training. That randomized, active-controlled, double-blind study enrolled 35 recreationally active male subjects between 35 and 55 years of age and randomly allocated them to one of three groups: an active group (2 grams Velositol + 15 grams whey protein), a low-dose comparator group (15 grams of whey protein), or a high-dose comparator group (30 grams of whey protein).
Results showed that Velositol plus whey led to significant increases in muscle protein synthesis. A non-significant increase in insulin to help initiate muscle growth was also reported, and blood glucose levels remained in the healthy, normal range.
A preclinical rat study (PMC, 2020) by the same research group examined the combination with BCAAs: this study showed that the addition of an amylopectin/chromium complex (ACr; Velositol®) to BCAAs improved MPS by 71% over the exercise controls, compared to a 57% increase in the BCAAs alone group. Overall, the results from this preclinical study support the use of an amylopectin/chromium complex as a bioactive sports nutrition ingredient to support MPS with BCAAs.
Critical limitations: The human clinical study had only 10 participants and was funded by Nutrition 21, the patent holder. The protein dose used (6 g whey) was deliberately "suboptimal," a design choice that may have amplified any apparent benefit. The mTOR pathway mechanism has not been directly confirmed in human tissue. The researchers themselves noted that further clinical research is needed, and that results may be of interest to athletic and fitness communities interested in supplementing with a dietary supplement in combination with a source of protein or amino acids to stimulate muscle anabolism.
Evidence summary: Moderate — small but specifically designed double-blind human studies in a patient population; clinically meaningful outcomes.
The most rigorously studied medical application of a high-amylopectin starch is in the treatment of hepatic glycogen storage diseases (GSD), particularly GSD type I.
Uncooked corn-starch (UCCS) has been the mainstay of therapy for the hepatic glycogen storage diseases, but is not always effective. A heat-modified waxy maize starch (WMHMS) has demonstrated a more favourable short-term metabolic profile, and a double-blind crossover study was conducted to determine its efficacy and safety over 16 weeks of treatment with each starch compared to UCCS. The double-blind cross-over study enrolled 10 adults (aged 16–38 years, six male) with GSD Ia and Ib. After an individualised fast, subjects were randomised to take a 50 g starch-load of either WMHMS or UCCS, and starch-loads were terminated when blood glucose was <3.0 mmol/L or the subject felt subjectively hypoglycaemic.
A retrospective pediatric case series examined waxy maize heat-modified starch in young children: glycogen storage disease type I (GSDI) is caused by deficiency of the enzyme glucose-6-phosphatase or glucose-6-phosphate transporter, and the mainstay of treatment is provision of uncooked cornstarch and/or continuous nocturnal pump feeds to maintain normoglycemia. Waxy maize heat-modified starch (WMHMS) is another treatment option to maintain normoglycemia overnight. Most patients successfully transitioned to nocturnal WMHMS feeds. These patients had stable glucose and lactate throughout the overnight period, permitting a fasting period of 6.5–8 hours overnight.
Evidence summary: Weak — limited and inconsistent data from available studies.
When male volunteers were given hot mixed lunches in which the amylose-to-amylopectin ratio (Am:Ap) was either 0:100 or 45:55, increasing the Am:Ap resulted in significantly lower initial glucose and insulin responses. The rises in free glycerol and free fatty acid concentrations that occurred after an initial drop were stronger at low Am:Ap. High-Am:Ap meals (i.e., amylose-dominant meals) induced more satiety up to 6 hours postprandially. This finding specifically contrasts high-amylopectin conditions with high-amylose conditions, and is consistent with the understanding that amylopectin-dominant starch tends to produce a higher glycemic spike followed by a more rapid decline — a pattern less conducive to sustained satiety than slower-digesting starches. Notably, the systematic review found that sufficient evidence was not found to suggest how structural factors (including amylose-to-amylopectin ratio) influence appetite.
The following dosages are reported as used in published clinical studies only, not as recommendations:
Velositol (amylopectin/chromium complex) is described as clinically proven to be safe and effective and maintains Generally Recognized As Safe (GRAS) status. The parent material — waxy maize starch — is a food ingredient with a long history of safe use in food processing, and amylopectin is a normal component of the human diet wherever starchy foods are consumed.
Because high-amylopectin starches produce a higher and faster postprandial glucose and insulin response than high-amylose starches, their use in individuals with impaired glucose tolerance, insulin resistance, or type 2 diabetes warrants caution. The sustained plasma glucose levels after an amylose meal with reduced insulin requirement suggest amylose starch may be of potential benefit to carbohydrate-sensitive or diabetic individuals — implying by contrast that amylopectin-dominant starch would produce a larger glycemic excursion in such individuals.
Summation of 0.5 through 2-hour levels of insulin were significantly lower after amylose compared with amylopectin. Mean fasting triglyceride and cholesterol levels were significantly lower during the period when amylose was consumed. Long-term intake of dietary amylose may be valuable in decreasing insulin response while maintaining proper control of glucose tolerance and low levels of blood lipids. The inverse implication is that chronically high intake of amylopectin-dominant starch, compared to amylose-dominant starch, was associated with less favorable lipid levels in this study population.
In the Velositol clinical study, blood glucose levels remained in the healthy, normal range. The chromium component of the complex contributes pharmacological activity beyond the amylopectin alone, as chromium picolinate and chromium histidinate are known to affect insulin sensitivity. Any drug interaction considerations pertaining to insulin-sensitizing agents (e.g., diabetes medications) would apply to this complex, not to amylopectin in isolation.
One practical advantage of waxy maize amylopectin over lower-molecular-weight carbohydrates (such as dextrose) in some athletes is its lower osmolality, which may reduce gastric discomfort during exercise. Commercial waxy maize preparations with high molecular weight (500,000 to 700,000 g/mol) and low osmolality are considered lower-risk for exercise-induced gastrointestinal distress compared to simple-sugar solutions of equivalent caloric content. This is a practical, not an absolute, safety benefit.
Amylopectin derived from corn (waxy maize) is gluten-free and does not naturally contain the major allergenic proteins. However, glutinous rice does not have dietary gluten and is safe for people who follow a gluten-free diet. Cross-contamination with other allergens may occur in manufacturing, and corn itself is considered an allergenic food for sensitive individuals, though corn allergy is far less prevalent than wheat or peanut allergy.
Since amylopectin is derived directly from a natural polysaccharide, it integrates well with tissues and cells. However, the mechanical properties of amylopectin are not optimal due to its high level of crosslinking — a limitation relevant to its use in pharmaceutical excipient and biomedical applications, but not to dietary supplementation.
Health conditions that Amylopectin may help support.
An amylopectin-chromium complex (Velositol®) has been studied in human clinical trials in the context of resistance training. A double-blind crossover RCT found that combining 2 g of the complex with 6 g whey protein increased muscle protein synthesis by 48% from baseline vs. 24% for whey alone. An 8-week randomized, active-controlled, double-blind trial in recreationally active men reported improvements in repetitions to failure and vertical jump power with the amylopectin-chromium plus whey protein condition.
Amylopectin's highly branched structure presents a large surface area to digestive enzymes, resulting in rapid hydrolysis and fast glucose absorption, which produces sharp postprandial blood glucose and insulin spikes compared to amylose-rich starches. Human and animal studies confirm that higher amylopectin-to-amylose ratios in the diet correlate with higher glycemic index values. Chronic high amylopectin intake has been linked to greater insulin resistance in animal models, raising relevance for blood sugar management.
Amylopectin is a high-glycemic-index carbohydrate that is rapidly digested to glucose, providing a fast-acting energy substrate for working muscles. Its rapid absorption makes it particularly relevant for replenishing muscle glycogen during or after prolonged exercise. Exercise nutrition research consistently identifies high-GI carbohydrates, including amylopectin-type starches, as the preferred fuel for immediate energy provision and glycogen resynthesis.
Amylopectin, via its high-GI rapid-glucose-release properties, supports post-exercise muscle glycogen resynthesis, a key component of physical recovery. As the carbohydrate component of the ACr complex (Velositol®), it has also been studied for its role in augmenting muscle protein synthesis post-exercise, with the 8-week RCT reporting VAS-assessed recovery benefits in addition to performance gains. Animal studies using ACr demonstrate enhanced mTOR-pathway signaling relevant to muscle repair.
Muscle glycogen, replenished by dietary carbohydrates including amylopectin-type starches, is a primary fuel for endurance exercise; its depletion is well-established to impair endurance capacity. High-GI carbohydrates such as amylopectin are recommended for rapid glycogen resynthesis between endurance bouts. Evidence from physiology reviews and controlled carbohydrate manipulation studies in athletes documents the link between carbohydrate quality, glycogen availability, and endurance performance.
Body systems that Amylopectin may help support.
Go back